X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-20 | CNTA | Rotman Harris | SVP Regulatory Affairs | S - Sale+OE | $6.29 | -37,484 | 33,500 | -53% | -$235,688 | |||||
2023-06-01 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $4.45 | -6,500 | 783,066 | -1% | -$28,949 | ||||||
2023-05-24 | CNTA | Bush Tia L | Chief Quality Officer | S - Sale | $4.48 | -8,000 | 157,102 | -5% | -$35,865 | ||||||
2023-05-01 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $4.42 | -6,800 | 789,566 | -1% | -$30,083 | ||||||
2023-04-03 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $3.69 | -6,700 | 796,366 | -1% | -$24,730 | ||||||
2023-03-01 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $3.42 | -7,000 | 806,681 | -1% | -$23,970 | ||||||
| D | 2023-02-01 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale+OE | $3.79 | -7,700 | 813,681 | -1% | -$29,201 | |||||
2023-01-04 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $3.18 | -6,970 | 751,913 | -1% | -$22,136 | ||||||
2022-12-01 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $3.91 | -9,400 | 761,151 | -1% | -$36,744 | ||||||
| A | 2022-10-03 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $3.91 | -9,500 | 1,570,002 | -1% | -$37,108 | |||||
2022-11-01 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $4.03 | -9,700 | 765,059 | -1% | -$39,055 | ||||||
| M | 2022-09-30 | CNTA | Chao David M | Chief Administrative Officer | S - Sale | $4.00 | -7,568 | 222,932 | -3% | -$30,293 | |||||
| M | 2022-09-30 | CNTA | Templeman Thomas | CTO | S - Sale | $4.00 | -4,458 | 135,792 | -3% | -$17,844 | |||||
| M | 2022-09-30 | CNTA | Grainger David J | Chief Innovation Officer | S - Sale | $4.00 | -5,181 | 936,075 | -1% | -$20,739 | |||||
| M | 2022-09-30 | CNTA | Weinhoff Gregory M | CFO | S - Sale | $4.00 | -8,901 | 231,099 | -4% | -$35,629 | |||||
| M | 2022-09-30 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $3.94 | -14,992 | 774,759 | -2% | -$59,091 | |||||
| M | 2022-09-30 | CNTA | Hussain Iqbal J | GC | S - Sale | $4.00 | -8,288 | 160,212 | -5% | -$33,175 | |||||
| M | 2022-09-30 | CNTA | Shahidi Javad | Chief Medical Officer | S - Sale | $4.00 | -6,068 | 158,932 | -4% | -$24,289 | |||||
| M | 2022-09-30 | CNTA | Bush Tia L | Chief Quality Officer | S - Sale | $4.00 | -4,713 | 143,287 | -3% | -$18,865 | |||||
2022-09-01 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $4.41 | -10,423 | 789,751 | -1% | -$45,987 | ||||||
2022-08-01 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $4.45 | -10,423 | 800,174 | -1% | -$46,405 | ||||||
2022-07-18 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $4.87 | -20,000 | 810,597 | -2% | -$97,312 | ||||||
2022-07-01 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $5.03 | -9,100 | 830,597 | -1% | -$45,797 | ||||||
2022-06-24 | CNTA | Saha Saurabh | CEO | P - Purchase | $4.63 | +10,000 | 38,000 | +36% | +$46,284 | ||||||
2022-06-17 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $4.68 | -9,200 | 739,697 | -1% | -$43,036 | ||||||
| M | 2022-05-17 | CNTA | Yver Antoine | EVP, COB of Development | S - Sale | $5.17 | -85,000 | 748,897 | -10% | -$439,734 | |||||
2022-02-02 | CNTA | Saha Saurabh | CEO | P - Purchase | $9.74 | +5,000 | 28,000 | +22% | +$48,700 | ||||||
2022-01-28 | CNTA | Grainger David J | Chief Innovation Officer | P - Purchase | $9.05 | +27,500 | 841,256 | +3% | +$248,754 | ||||||
2021-12-02 | CNTA | De Rubertis Francesco | Dir | P - Purchase | $12.82 | +34,326 | 14,186,922 | 0% | +$440,059 | ||||||
2021-12-02 | CNTA | Medicxi Ventures Management (Jersey) Ltd | 10% | P - Purchase | $12.82 | +34,326 | 14,186,922 | 0% | +$440,059 | ||||||
| M | 2021-11-30 | CNTA | De Rubertis Francesco | Dir | P - Purchase | $12.24 | +97,151 | 14,186,126 | +1% | +$1,189,199 | |||||
| M | 2021-11-30 | CNTA | Medicxi Ventures Management (Jersey) Ltd | 10% | P - Purchase | $12.24 | +97,151 | 14,186,126 | +1% | +$1,189,199 | |||||
| M | 2021-11-26 | CNTA | De Rubertis Francesco | Dir | P - Purchase | $11.64 | +68,523 | 14,183,872 | 0% | +$797,426 | |||||
| M | 2021-11-26 | CNTA | Medicxi Ventures Management (Jersey) Ltd | 10% | P - Purchase | $11.64 | +68,523 | 14,183,872 | 0% | +$797,426 | |||||
2021-11-18 | CNTA | Kantoff Aaron | Dir | P - Purchase | $11.99 | +10,000 | 60,000 | +20% | +$119,850 | ||||||
2021-11-16 | CNTA | Saha Saurabh | CEO | P - Purchase | $12.28 | +23,000 | 23,000 | New | +$282,472 | ||||||
2021-11-16 | CNTA | Bush Tia L | Chief Quality Officer | P - Purchase | $12.46 | +5,000 | 8,000 | +167% | +$62,302 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |